YSB Inc. (HKG:9885)
Hong Kong
· Delayed Price · Currency is HKD 6.29
-0.01 (-0.16%)
Apr 24, 2025, 4:08 PM HKT
YSB Inc. Revenue
In the year 2024, YSB Inc. had annual revenue of 17.90B CNY with 5.49% growth. YSB Inc. had revenue of 9.09B in the half year ending December 31, 2024, with 20.31% growth.
Revenue
17.90B CNY
Revenue Growth
+5.49%
P/S Ratio
0.23
Revenue / Employee
2.65M CNY
Employees
6,763
Market Cap
4.29B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.90B | 931.33M | 5.49% |
| Dec 31, 2023 | 16.97B | 2.70B | 18.90% |
| Dec 31, 2022 | 14.27B | 4.18B | 41.43% |
| Dec 31, 2021 | 10.09B | 4.03B | 66.43% |
| Dec 31, 2020 | 6.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Akeso | 2.26B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| CSPC Pharmaceutical Group | 30.87B |